Guardian Pharmacy Services, Inc.
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.46B | 1.45B | 1.39B | 1.33B | 1.28B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.46B | 1.45B | 1.39B | 1.33B | 1.28B |
| Cost of Revenue | 1.15B | 1.16B | 1.12B | 1.07B | 1.03B |
| Gross Profit | 304.68M | 292.72M | 274.32M | 260.48M | 253.62M |
| SG&A Expenses | 216.46M | 212.07M | 213.32M | 320.71M | 310.90M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.37B | 1.37B | 1.33B | 1.39B | 1.34B |
| Operating Income | 88.22M | 80.64M | 61.00M | -60.24M | -57.28M |
| Income Before Tax | 78.61M | 73.42M | 58.55M | -63.73M | -57.68M |
| Income Tax Expenses | 25.38M | 24.47M | 19.01M | 12.15M | 8.39M |
| Earnings from Continuing Operations | 53.23 | 48.96 | 39.53 | -75.88 | -66.07 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -163.00K | 261.00K | 705.00K | -6.34M | -11.77M |
| Net Income | 53.07M | 49.22M | 40.24M | -82.22M | -77.84M |
| EBIT | 88.22M | 80.64M | 61.00M | -60.24M | -57.28M |
| EBITDA | 111.27M | 102.98M | 82.74M | -39.33M | -36.99M |
| EPS Basic | 0.74 | 0.71 | 0.21 | -1.79 | -1.72 |
| Normalized Basic EPS | 0.78 | 0.75 | 0.56 | -0.81 | -0.88 |
| EPS Diluted | 0.73 | 0.70 | 0.20 | -1.80 | -1.72 |
| Normalized Diluted EPS | 0.77 | 0.74 | 0.55 | -0.82 | -0.88 |
| Average Basic Shares Outstanding | 314.13M | 311.58M | 310.30M | 309.32M | 308.42M |
| Average Diluted Shares Outstanding | 317.64M | 316.08M | 315.19M | 312.90M | 310.84M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -14.97% | -37.15% |